Michael J. Lucido

702 total citations
9 papers, 473 citations indexed

About

Michael J. Lucido is a scholar working on Pharmacology, Biological Psychiatry and Behavioral Neuroscience. According to data from OpenAlex, Michael J. Lucido has authored 9 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Biological Psychiatry and 3 papers in Behavioral Neuroscience. Recurrent topics in Michael J. Lucido's work include Tryptophan and brain disorders (4 papers), Stress Responses and Cortisol (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Michael J. Lucido is often cited by papers focused on Tryptophan and brain disorders (4 papers), Stress Responses and Cortisol (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Michael J. Lucido collaborates with scholars based in United States and China. Michael J. Lucido's co-authors include Benjamin J. Orlando, Michael G. Malkowski, Alex J. Vecchio, Michael T. Treadway, Jennifer C. Felger, Mandakh Bekhbat, Ebrahim Haroon, Andrew H. Miller, David R. Goldsmith and Zhihao Li and has published in prestigious journals such as Biochemistry, Pharmacological Reviews and Archives of Biochemistry and Biophysics.

In The Last Decade

Michael J. Lucido

9 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Lucido United States 7 153 131 110 93 65 9 473
Julia Liang Australia 11 53 0.3× 87 0.7× 231 2.1× 65 0.7× 191 2.9× 37 592
Cody J. Wenthur United States 17 119 0.8× 132 1.0× 426 3.9× 57 0.6× 91 1.4× 43 987
Wen-Fei Chiou Taiwan 15 184 1.2× 199 1.5× 250 2.3× 122 1.3× 28 0.4× 22 822
Seo Yun Jung South Korea 16 89 0.6× 61 0.5× 232 2.1× 60 0.6× 12 0.2× 44 564
Philip A. Krieter United States 15 157 1.0× 79 0.6× 175 1.6× 55 0.6× 24 0.4× 21 792
Rai Khalid Farooq Saudi Arabia 19 153 1.0× 335 2.6× 217 2.0× 270 2.9× 118 1.8× 43 1.0k
Eleni Pitsillou Australia 11 43 0.3× 64 0.5× 200 1.8× 62 0.7× 176 2.7× 34 524
Gabriela Starowicz Poland 12 92 0.6× 69 0.5× 119 1.1× 82 0.9× 29 0.4× 16 401
Gilda Neves Brazil 13 70 0.5× 88 0.7× 198 1.8× 42 0.5× 19 0.3× 35 562
Nahid Fakhraei Iran 12 35 0.2× 74 0.6× 75 0.7× 49 0.5× 16 0.2× 30 375

Countries citing papers authored by Michael J. Lucido

Since Specialization
Citations

This map shows the geographic impact of Michael J. Lucido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Lucido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Lucido more than expected).

Fields of papers citing papers by Michael J. Lucido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Lucido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Lucido. The network helps show where Michael J. Lucido may publish in the future.

Co-authorship network of co-authors of Michael J. Lucido

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Lucido. A scholar is included among the top collaborators of Michael J. Lucido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Lucido. Michael J. Lucido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lucido, Michael J. & Boadie W. Dunlop. (2025). Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges. Brain Sciences. 15(2). 161–161. 3 indexed citations
2.
Li, Zhihao, Boadie W. Dunlop, Michael T. Treadway, et al.. (2024). Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation. Brain Behavior and Immunity. 125. 240–248. 8 indexed citations
3.
Bekhbat, Mandakh, Zhihao Li, Michael T. Treadway, et al.. (2022). Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Molecular Psychiatry. 27(10). 4113–4121. 60 indexed citations
4.
Rakofsky, Jeffrey J., Michael J. Lucido, & Boadie W. Dunlop. (2022). Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis. Journal of Affective Disorders. 308. 268–280. 10 indexed citations
5.
Lucido, Michael J., Mandakh Bekhbat, David R. Goldsmith, et al.. (2021). Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications. Pharmacological Reviews. 73(3). 1084–1117. 67 indexed citations
6.
Lucido, Michael J., Benjamin J. Orlando, Alex J. Vecchio, & Michael G. Malkowski. (2016). Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry. 55(8). 1226–1238. 173 indexed citations
7.
Orlando, Benjamin J., Michael J. Lucido, & Michael G. Malkowski. (2014). The structure of ibuprofen bound to cyclooxygenase-2. Journal of Structural Biology. 189(1). 62–66. 132 indexed citations
8.
Orlando, Benjamin J., Daniel R. McDougle, Michael J. Lucido, et al.. (2014). Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs. Archives of Biochemistry and Biophysics. 546. 33–40. 18 indexed citations
9.
Lucido, Michael J.. (2011). Effects of Neurofeedback on Neuropsychological Functioning in an Adult with Autism. ScholarWorks (Walden University). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026